Compositions and methods for treating cancer
US9402865B2 · kind B2 · utility
44Cited by
25References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 18, 2012 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Apr 29, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods for treating ovarian cancer. Specifically, the invention relates to administering a genetically modified T cell having α-folate receptor (FRα) binding domain and 4-1BB (CD137) costimulatory domain to treat ovarian cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.